SurModics

$43.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.29 (-2.90%) As of 1:57 PM EDT today
-$1.29 (-2.90%) Today

Why Robinhood?

You can buy or sell SurModics and other stocks, options, ETFs, and crypto commission-free!

About SRDX

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. Read More The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Employees
338
Headquarters
Eden Prairie, Minnesota
Founded
1979
Market Cap
600.21M
Price-Earnings Ratio
276.16
Dividend Yield
0.00
Average Volume
92.46K
High Today
$44.67
Low Today
$43.05
Open Price
$43.90
Volume
33.06K
52 Week High
$82.35
52 Week Low
$38.06

Collections

SRDX News

ReutersAug 6

Edited Transcript of SRDX earnings conference call or presentation 31-Jul-19 9:00pm GMT

5
BenzingaAug 1

The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings

3

SRDX Earnings

-$0.24
-$0.07
$0.10
$0.27
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Nov 8, After Hours

More SRDX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.